399 related articles for article (PubMed ID: 23576437)
1. Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.
Bettaieb A; Nagata N; AbouBechara D; Chahed S; Morisseau C; Hammock BD; Haj FG
J Biol Chem; 2013 May; 288(20):14189-14199. PubMed ID: 23576437
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice.
Liu Y; Dang H; Li D; Pang W; Hammock BD; Zhu Y
PLoS One; 2012; 7(6):e39165. PubMed ID: 22720061
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of soluble epoxide hydrolase in adipose tissue.
De Taeye BM; Morisseau C; Coyle J; Covington JW; Luria A; Yang J; Murphy SB; Friedman DB; Hammock BB; Vaughan DE
Obesity (Silver Spring); 2010 Mar; 18(3):489-98. PubMed ID: 19644452
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
6. Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.
Liu L; Puri N; Raffaele M; Schragenheim J; Singh SP; Bradbury JA; Bellner L; Vanella L; Zeldin DC; Cao J; Abraham NG
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():1-8. PubMed ID: 30041041
[TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.
Luria A; Bettaieb A; Xi Y; Shieh GJ; Liu HC; Inoue H; Tsai HJ; Imig JD; Haj FG; Hammock BD
Proc Natl Acad Sci U S A; 2011 May; 108(22):9038-43. PubMed ID: 21571638
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.
Bettaieb A; Koike S; Hsu MF; Ito Y; Chahed S; Bachaalany S; Gruzdev A; Calvo-Rubio M; Lee KSS; Inceoglu B; Imig JD; Villalba JM; Zeldin DC; Hammock BD; Haj FG
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2758-2765. PubMed ID: 28757338
[TBL] [Abstract][Full Text] [Related]
9. Genetic deficiency or pharmacological inhibition of soluble epoxide hydrolase ameliorates high fat diet-induced pancreatic β-cell dysfunction and loss.
Koike S; Hsu MF; Bettaieb A; Chu B; Matsumoto N; Morisseau C; Havel PJ; Huising MO; Hammock BD; Haj FG
Free Radic Biol Med; 2021 Aug; 172():48-57. PubMed ID: 34038767
[TBL] [Abstract][Full Text] [Related]
10. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
11. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
[TBL] [Abstract][Full Text] [Related]
12. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease.
Mello A; Hsu MF; Koike S; Chu B; Cheng J; Yang J; Morisseau C; Torok NJ; Hammock BD; Haj FG
Cell Mol Gastroenterol Hepatol; 2021; 11(3):815-830. PubMed ID: 33068774
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
[TBL] [Abstract][Full Text] [Related]
14. Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue.
Kawasaki N; Asada R; Saito A; Kanemoto S; Imaizumi K
Sci Rep; 2012; 2():799. PubMed ID: 23150771
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase as a therapeutic target for obesity-induced disorders: roles of gut barrier function involved.
Zhang J; Tu M; Liu Z; Zhang G
Prostaglandins Leukot Essent Fatty Acids; 2020 Nov; 162():102180. PubMed ID: 33038829
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.
Bettaieb A; Koike S; Chahed S; Zhao Y; Bachaalany S; Hashoush N; Graham J; Fatima H; Havel PJ; Gruzdev A; Zeldin DC; Hammock BD; Haj FG
FEBS J; 2017 Jul; 284(13):1970-1986. PubMed ID: 28485854
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy.
Jiang XS; Xiang XY; Chen XM; He JL; Liu T; Gan H; Du XG
Cell Death Dis; 2020 May; 11(5):385. PubMed ID: 32439839
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney.
Luo J; Hu S; Fu M; Luo L; Li Y; Li W; Cai Y; Dong R; Yang Y; Tu L; Xu X
J Biol Chem; 2021; 296():100667. PubMed ID: 33864813
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]